The second United Nations High-Level Meeting on Tuberculosis is taking place in New York today. Sihle Mahonga Ndawonde argues that better TB data and more transparency are needed in South Africa if we are to get and stay on the road to meeting the ambitious targets set and endorsed at this UN meeting.
Almost two years ago, a study found that a breakthrough four-month treatment regimen for tuberculosis is as effective as the current six-month regimen. The time is now to join together for the thoughtful implementation of this new regimen, argue Yuri F. van der Heijden, Violet Chihota, and Salome Charalambous.
Despite advances in paediatric TB care, substantial challenges remain. If we are to heed the call for this year’s World TB Day – ‘Yes! We can end TB’ – we will need to significantly ramp up dedicated investment for an integrated approach to addressing TB in children, argues Dr Sipho Nyathi.
The South African TB Recovery Plan was developed to try and reverse the negative effects of the COVID-19 pandemic on the country’s TB response. On World TB Day, authors from TB Proof (a leading TB activist group) assess how the recovery is going and identify four key areas where further intervention is needed.
While there is a long way to go, there has been important progress in South Africa’s response to tuberculosis (TB) and 2023 is set up to be a watershed year for the fight against the disease both globally and in South Africa. As we commemorate World TB Day, let us all pledge to make this year’s theme a reality – “Yes! You and I can end TB”, write Gaurang Tanna and Yogan Pillay.
The uptake and continuation of tuberculosis preventive therapy were much higher when it was provided through a community-based model compared to the standard clinic-based model, a study conducted in KwaZulu-Natal found. Elri Voigt unpacks the study findings, which were recently presented at the Conference for Retroviruses and Opportunistic Infections in Seattle, USA.
The current treatment for drug-susceptible tuberculosis (TB) used in South Africa last for six months, effectively cures TB and is dirt cheap. Two studies in recent years have shown that TB can be cured in four or in some cases even two months, but price and other complications make these treatments tricky to implement. At a conference in Seattle last week, a major trial of an alternative four-month treatment reported disappointing findings. Elri Voigt unpacks the latest findings and asks what the prospects now are for shortening TB treatment.
South Africa’s National Department of Health is set to receive a donation of child-friendly formulations of several medicines used to treat drug-resistant tuberculosis (DR-TB). It is expected that over the next year the donation will spare roughly 200 children the substantial difficulties associated with taking DR-TB medicines meant for adults.
An HIV prevention injection approved in South Africa, several promising developments on the tuberculosis front, the National Health Insurance Bill grinding its way through Parliament, no end in sight to healthcare worker shortages, another dire year for health in Gauteng – Spotlight wraps up 2022 in under 1 000 words.
Diagnosing tuberculosis is difficult in people who struggle to cough up sputum samples – a particular problem in children and people living with HIV. One promising alternative to testing sputum is to test stool. Tiyese Jeranji unpacks the latest developments in this area.
Falling ill with tuberculosis (TB) can be challenging for anyone, but it can be especially hard if you are pregnant or have just given birth. Globally, TB is amongst the top five causes of death in women of childbearing age. Tiyese Jeranji spoke to experts about the risks, challenges, and ongoing studies on maternal TB.
Some cases of tuberculosis (TB) can be successfully treated in as little as two months – a third of the current standard of six months. This is according to early findings from the landmark TRUNCATE TB trial presented at last week’s Union World Conference on Lung Health. Elri Voigt reports.
